Abstract-Glucometers present an important selfmonitoring tool for diabetes patients and, therefore, must exhibit high accuracy as well as good usability features. Based on an invasive photometric measurement principle that drastically reduces the volume of the blood sample needed from the patient, we present a framework that is capable of dealing with small blood samples, while maintaining the required accuracy. The framework consists of two major parts: 1) image segmentation; and 2) convergence detection.
D
IABETES Mellitus describes a group of metabolic diseases, affecting 347 million people worldwide. It occurs when the pancreas cannot produce enough insulin or when the body cannot use the insulin it produces [1] . The healthy glucose range lies between 70 and 180 mg/dl [2] . A condition termed hypoglycaemia occurs when the blood sugar level drops below 70 mg/dl. This condition is associated with a high short-term risk. Hyperglycaemia, in contrast, occurs for blood sugar levels above 200 mg/dl and has longer term effects on the body functions. Several studies have been able to statistically associate a significant delay of the onset, or slowing down the progression of complications through intensive treatment guided by frequent blood glucose self-monitoring [3] , [4] . For this purpose, handheld invasive devices containing glucose biosensors are used by patients to regularly and reliably self-monitor their glucose levels. This typically requires to extract a blood sample from the patient's finger using a lancet up to four to five times daily and can, therefore, present a hurdle to regular self-control. To reduce the inhibition and pain threshold for the patient, we present a framework based on a novel approach that uses a blood sample in the nanoliter-range (nl-range), which is up to a magnitude of 100 smaller than is common in current state-of-the-art devices [5] , [6] , hereby drastically reducing the pain sensation for the patient.
The approach used in our work, illustrated in Fig. 1 , is based on a photometric measurement principle, where the blood sample is placed on a chemical test strip that reacts with the blood glucose, resulting in a color change. By illuminating the test area and capturing the reflections, the color change can be measured and associated with the underlying glucose level. To counter the common problem of ambient light noise [7] in photometry, the measurement area is placed completely inside the device and, thus, protected from ambient light. In this approach, the blood sample, and thus the region where the reaction takes place, is very small compared to the chemical test strip. The whole test strip is observed by an image sensor resulting in frames at discrete time instants n = n 0 , n 1 , . . ., where n = tf s , t ∈ R being the continuous time and f s is the sampling frequency. The frames show both the region where the reaction takes place and surrounding areas. The former represents the region of interest (ROI) and has to be extracted. The underlying intensity value representing the color change is termed relative remission r ∈ R, which is, finally, mapped to the underlying glucose concentration g ∈ R. This process is carried out for the whole duration of the chemical reaction, producing a set of frames. Typically, the chemical reaction exhibits three different stages.
1) Constant relative remission where the reaction between the glucose and the chemical agent has not started. 2) The moistening period starts at n = n D and is characterized by a rapid drop of the relative remission value r D followed by a slow decrease, which can be modeled by an exponential decay. 3) Convergence is reached when the chemical reaction saturates at n = n C at a converged remission value r C . Fig. 2 depicts an idealized course of a typical chemical reaction for a low-and a high-glucose case. Different behaviors of the frames can be observed depending on the stage and the underlying glucose concentration. Fig. 3 (a) and (d) shows that frames captured before the chemical reaction starts are characterized by a constant intensity over the whole region. With the onset of the chemical reaction, the ROI starts to shift in the direction of lower intensity. Depending on the underlying glucose concentration, the intensity will converge to a different final relative remission value r C . For the low-glucose range [see Fig. 3 (b) and (e)], this can be very close to the initial reflectance behavior of the constant stage (n < n D ), whereas for high-glucose concentrations [see Fig. 3 (c) and (f)], at least three distinct areas can typically be identified. The ROI itself is best recognizable as the area between the dotted lines in Fig. 3(c) . It is characterized by a granular structure. Furthermore, we observe a thick edge between the ROI and the background that takes on values that lie in between both areas. In Fig. 3(c) , it is the area between the solid and the dotted line. This occurs due to the inhomogeneous distribution of the blood sample over the edges, such that a weaker reaction takes place in this area. As the images are often degraded by noise, it can be difficult to distinguish the ROI from the other image regions, particularly in low-contrast cases. The position of the ROI is unknown, as it depends on the blood flow over the test strip, as well as movements of the test strip in the camera field. Moreover, the ROI is often disturbed by artefacts such as air bubbles or dust particles that can change their position, size, and shape during the reaction. The result of this is a change in the number and position of clusters in the image over time as well as for different glucose concentrations.
The main contribution of this work is the development of a framework to measure the concentration of an analyte in a fluid from an image-based measurement procedure, in our case the glucose concentration in blood. It is noteworthy that this framework is not confined to this sole application but is suitable for other medical applications that rely on photometry. We show that our framework exhibits high accuracy, while reducing the blood sample volume from the microliter-range (μl-range) to the nl-range. The proposed methodology entails: 1) the detection of the onset of the chemical reaction, using a NeymanPearson hypothesis test; 2) the segmentation of the ROI and accurate estimation of the underlying relative remission value for each incoming frame at time instant n = n D , . . . , n C without prior knowledge on the number or shape of the regions. We build up on our previous work in [8] and [9] , by incorporating the median instead of the mean which exhibits better performance, as well as, providing convergence proofs for all the derived methods. Furthermore, a data-driven heuristic is introduced to choose the subset size individually for the scalable version, which further reduces the subset size in most cases; 3) the derivation of a model for the chemical kinetics that is incorporated in a temporal tracking and prediction setup to enhance accuracy and reduce measurement time drastically; 4) the mapping of the estimated remission to the underlying glucose concentration. The validation of our proposed framework is performed on an extensive collection of real datasets taken in six different scenarios to ensure robustness of the framework in different settings. Using these sets, we are able to identify a minimum range for the blood sample volume to maintain the required accuracy. We note that some aspects of this work ap-peared in [8] - [10] , while the substantial part of this paper is novel.
Some notation: In this work, scalars are represented by lowercase nonbold letters a, while lowercase bold letters denote vectors a and a l indicates the lth element of the vector. Capital bold letters are matrices A and constants are given by capital nonbold letters A. We denote estimates byâ and sets by A. The use of n in the superscript denotes time indices a (n ) and j in the superscript denotes iteration steps a (j ) . This paper is organized as follows: In Section II, we discuss the state of the art. Section III presents the proposed framework, detailing the different challenges and stages of the procedure. It includes proofs of convergence of the proposed weighted meanshift (MS) and medoid-shift algorithms. Section IV introduces the used datasets as well as the validation criteria. The main part of this section comprises the experiments and the discussion thereof. We conclude with a summary and an overview on future work in Section V.
II. STATE OF THE ART
Traditionally, glucose self-monitoring devices are based on an invasive procedure that uses a photometric or an electrochemical approach to infer the glucose concentration from the blood sample [6] , [11] , [12] . This requires the extraction of a blood volume of 1-25 μl. While much research is being performed to replace the current devices by noninvasive alternatives [13] - [15] , it seems that the traditional technologies will continue to maintain their position [6] , at least in the near future. Reducing the blood volume needed and hereby the induced pain remains a necessary field of research [6] . Traditional photometric measurement principles use a blood sample in the μl-range that completely covers up the test field. A photodiode is applied to capture the resulting reflections [16] . The use of much smaller blood samples renders this approach inaccurate, as the ROI becomes much smaller and the signal-to-noise ratio rises. This motivates the use of a camera to observe the chemical reaction.
To the best of our knowledge, the problem of measuring blood glucose using the setup in Fig. 1 and an image processing-based approach has only been tackled in a limited number of studies. In [5] , the authors propose to use a histogram-based approach and the setup in Fig. 1 to estimate the intensity of the ROI. To this end, two clusters are assumed: one corresponding to the ROI and the other to the background. The authors propose to measure the displacement of the ROI cluster w.r.t. the background cluster. The underlying assumptions are that just two clusters exist in the image and that the background cluster exhibits a constant relative remission value over time. These are rather strong assumptions, which are hardly fulfilled in practice. Our observations give evidence to a variable number of clusters in the images, as seen in Fig. 3 . The variability is glucose levelspecific, temporally dependent, and caused by the variability of the chemical reaction for different blood samples of different patients. Furthermore, the background cluster does not experience a constant intensity but changes over time due to temperature and humidity issues, as well as leakage of small amounts of blood to the background cluster. We assume that the number of clusters in the images is unknown and propose an approach that is able to deal systematically with this. 
III. PROPOSED ALGORITHM
Our framework is summarized in Fig. 4 . The input is given by the frames obtained by the camera, representing the reflectivity behavior of the observed area. Each incoming frame is directly processed. A hypothesis test is performed on the preprocessed gray-scale reflectance image X (n ) of size M x × M y , obtained at frame n, to detect whether the chemical reaction has started, i.e., if n ≥ n D . In this case, we proceed by segmenting the ROI. After segmenting the image, the relative remission values of the different regions are estimated and the converged relative remission valuer C corresponding to the ROI is identified. The current estimate along with the history of estimates is used to test for convergence of the chemical reaction. If convergence is detected, the underlying intensity value is mapped to its corresponding glucose levelĝ. If not, the next frame is processed in the same manner. The different blocks as depicted in Fig. 4 will be described in further detail in the following.
A. Preprocessing
The raw frames X (n ) raw obtained by the camera are normalized w.r.t. the initial reflectivity prior to the start of the chemical reaction. The normalization is performed using the calibration frames as described in [8] and results in a gray-level image X (n ) norm with pixels in the range between 0 and 100. In our previous work [8] , we asserted that windowing the images results in superior segmentation and remission estimation results. We termed this process binning and used B to denote the size of the window. Binning is used as the last step in the preprocessing stage unless stated otherwise. Finally, the preprocessed image is denoted by X (n ) .
B. Detection of Drop Time
As illustrated in Fig. 2 , the chemical reaction exhibits a constant stage for n < n D , where the glucose in the blood sample has not yet been detected. The time n D when the drop occurs, i.e., when the chemical reaction starts, is dependent on the particular chemical reagent, the blood sample at hand, and the underlying temperature and humidity conditions in the device. We suggest using the Neyman-Pearson hypothesis test of variance to detect n D . The advantage of using the Neyman-Pearson test is that it provides a meaningful way to set a threshold by incor- porating the image statistics and controlling the false-alarm rate. Fig. 5 illustrates the probability density functions (pdfs) fx of the intensities of two exemplary images taken at time n 1 < n D and n C > n 2 > n D , i.e., directly after the occurrence of the drop. Extensive analysis of real data showed that it is reasonable to assume that the mean-adjusted frames for n < n D follow a zero-mean normal distribution with variance σ 2 1 , whereas after the drop, the mean-adjusted frames can be modeled by a zero-mean normal distribution with variance σ For the remainder of this work, we will deal with vectorized forms of the images and denote these by
where
the hypothesis test can be formulated as
is the mean-adjusted version of x (n ) and fx(n ) denotes the pdf ofx (n ) . Calculating the likelihood-ratio leads to the following test statistic:
where the threshold δ is set to ensure a nominal false alarm rate. Assumingx (n ) to be spatially i.i.d., the distribution of
under H 1 can be shown to follow a χ 2 -distribution with L degrees of freedom [17] . The spatial i.i.d. assumption is justifiable in our case as we are observing frames prior to the onset of the reaction where no structure is present in the image. L represents the number of pixels in an image and is, therefore, quite large. Thus, we can approximate the χ 2 -distribution by a Gaussian distribution [17] and the probability of false alarm P FA becomes
where Q(·) is the complementary cumulative distribution function of the standard Gaussian distribution. Given a fixed probability of false alarm P FA , the threshold can be calculated as
C. Segmentation Using the MS Algorithm 1) Standard MS Algorithm: Our underlying assumption is that the glucose images will contain an ROI, where the blood sample is distributed, and thus, the color change of the ROI represents the reflectivity caused by the underlying glucose concentration. This area will not necessarily be completely spatially connected as it may contain artefacts where the reaction has not taken place, or granularities in the chemical that do not contribute to a proper reaction. Other areas in the image will not correspond to the ROI, either, because the blood sample is unevenly distributed in these areas, or because the areas are dry, i.e., not covered with blood. We interpret the different areas contained in the image as clusters with specific cluster centers overlaid by noise. We assume that data points converging to a certain cluster center will belong to the corresponding area. The noise here is assumed to be Gaussian. This assumption is based on the calibration frames where no reaction has started.
The MS algorithm [18] has become a popular approach for clustering and mode location estimation. It has been widely applied for medical image segmentation as it does not require the knowledge of the actual number of clusters [8] , [19] - [22] . We use the MS algorithm, as well as two extensions of it: the robust mean-shift (R-MS) [9] and the scalable sparse meanshift (SS-MS) [10] . Furthermore, we extend these variants to the medoid-shift [23] .
Assume a set of L pixels in a gray-scale image 1 at frame n that can be expressed as x
. . , L as in (1). We will omit the frame notation, henceforth, for better readability.
A consistent estimator of the density is given by the kernel density estimator (KDE) [24] with bandwidth parameter ĥ
where K(x) is a radially symmetric kernel function with a strictly decreasing profile for x ≥ 0. The bandwidth h of the kernel function is the only parameter that has to be tuned and is crucial to the performance of the MS algorithm, as it affects the number of clusters. Extensive work has dealt with the choice of the bandwidth parameter, e.g., [24] , [25] . Generally, the MS algorithm is derived by taking the zeros of the gradient of the KDE
and reformulating to get the MS vector of x as
where K = dK dx . Each data point is shifted according to (7) in the direction of steepest ascent until convergence, such that the sequence of successive locations of a data vector
where x (j ) denotes the jth iteration step. Typically, the MS algorithm tends to overestimate the number of modes. It is usual to postprocess the MS results with a simple clustering method to group nearby modes together, e.g., using a mode pruning step with bandwidth h [8] , [19] .
Another way to express the KDE, which allows for extensions of the MS, is to consider the kernel to be an inner product in the Hilbert space H, such that [26] 
where Φ : R d → H is a mapping function and · denotes the inner product. K(
) is a positive-definite kernel function. Hence, the KDE can be formulated aŝ
In this formulation, the uniform weights 1 L have been substituted by w l > 0 to attain a more general form. It has been shown [19] that the MS algorithm converges and that the mode estimator is asymptotically consistent and unbiased.
2) R-MS Algorithm: In [9] , the R-MS is derived as an alternative to account for heavy-tailed noise in the data. Here, the sample mean of vectors in (10) is substituted by a robust M-estimateμ
where ρ(·) is a monotone differentiable loss function, such as Huber's loss function [27] and the scaleσ is initialized with a robust estimate based on the mean absolute deviation (MAD) [9] . This leads to the robust KDÊ
where the robust weights w R-MS l can be determined using iteratively reweighted least squares (IRWLS) [9] , [28] , resulting in
where ψ = ρ . The R-MS vector reads
For a more detailed description of the R-MS, the reader is referred to [9] .
3) SS-MS Algorithm:
The computational complexity of the MS algorithm is proportional to the square of the total number of data points L. To overcome the problem of high computational demand, a scalable sparse version has been derived in [10] . A more detailed discussion of the computational complexity of both versions is provided in [10] . Using only a subset of the data points, the SS-MS is able to achieve high accuracy while reducing computational power. The gist lies in substituting the mean in (10) by a sparse approximation [29] , [30] . A short outline will be given in the following; for more details, the reader is referred to [10] . The sparse approximation of the mean can be formulated as
where the index set I ⊆ {1, . . . , L} of cardinality |I| = N is defined to be a subset of the full set of indices, the weights follow α ∈ R N and 1 ≤ N L. The scalable sparse KDÊ
where α I * ,i denotes the ith weight obtained using the optimal set I * . The resulting MS vector has the form
A robust sparse formulation (RSS-MS) can be derived [10] . To solve (15), we need to: 1) find a solution for the inner optimization problem, i.e., solve for α; and 2) find an optimal set I * . For a fixed I,
where Ξ I is the Gram matrix. To ensure convergence, α i < 0, ∀i = 1, ..., N . Generally, α i will not always fulfill the property. We, therefore, normalize the weights α i by setting to zero all weights α i < 0 and renormalizing such that i α i = 1. where
This is intuitive in the sense that to find the most representative subset of data vectors, we choose the ones that are most incoherent to each other. In [10] , we outline an algorithm to maximize ν I and determine I * . The question remaining is how to choose the cardinality N of the subset of indices I. Clearly, in some cases, this can be given by the application at hand knowing a certain N max , or by using test data for cross-validation, as in [10] , where N is set to be sufficiently high to incorporate the worst-case scenario. We introduce a data-driven selection of N , which results in a smaller N for most datasets than crossvalidation. Fig. 6 shows typical examples of the progression of a normalized version of ν I
for the images given in Fig. 3 , using different values of N = 1, . . . , L. We observe that the value of ν I drops quickly after a certain value of N and that the behavior of the curve is similar for different images. This signifies that the first N ν samples chosen by the algorithm contribute highly to the incoherence in the image and it is sufficient to use a subset I of cardinality N ν for the sparse representation. We propose to choose N ν based on the gradient of ν I in Fig. 6 and set a threshold T ν
The choice of T ν is based on heuristics and chosen specifically for the data at hand by observing the tradeoff between accuracy and computation. 4) Convergence Properties of the Derived Algorithms: It remains to prove that the MS algorithm in all its variations will converge. In [19] , the convergence proof of the standard MS is given. We extend it for the cases of the R-MS and the SS-MS.
Theorem 1: If w l > 0 holds for the weights from (10) and the kernel function K(·) has a convex and monotonically decreasing profile, the sequence of trajectory points {x (j ) }, j = 1, 2, . . . will converge and the sequence {f K x (j ) }, j = 1, 2, . . . is monotonically increasing. 
D. Segmentation Using the Medoid-Shift Algorithm
The medoid-shift was derived by Sheikh et al. [23] as an alternative to the MS that uses the medoid instead of the mean. The medoid is defined as the point in the set that has the smallest distance to all other points. We derive here a robust medoid-shift and a sparse scalable medoid-shift. This results in the following formulation for successive locations of x:
where w l represents the weights associated with each kernel. 
Unlike the MS, the medoid-shift always converges to points contained in the dataset. The advantage of this is that the medoidshift vector needs only to be computed once for every data sample and, hence, needs less iterations than the MS. Moreover, it does not need a further heuristic like the MS to group together neighboring clusters. The convergence of the sequence of trajectory points in the medoid-shift is guaranteed and the proof is analogous to that of the MS. The only difference is that for the medoid-shift, we additionally need to ensure that there are no cycles in the sequence of trajectory points, i.e., x (j ) = x (j +c) , for all c > 0. The proof thereof is given in Appendix B.
E. Cluster Assignment
The segmentation leaves us with a finite number of cluster centers corresponding to the different image regions. Typically, we attain two to four clusters: 1) one corresponding to the ROI, 2) another to the dry test strip area and optionally 3) one to the border between the dry area and the ROI, and 4) one corresponding to artefacts in the image. We need to identify which cluster center corresponds to the ROI. This can be done using a data-driven approach, exploiting information from the structure of the images. Using the size of the clusters, we can identify the background region and the ROI, as they are the largest. The ROI will correspond to the one exhibiting the lower intensity of the two remaining regions according to the nature of the chemical reaction.
F. Convergence Test
Convergence of the chemical reaction is a very crucial issue for the estimation accuracy. Ideally, the chemical kinetic curve evolves as in Fig. 2 . Final convergence is typically reached after 10-15 s. This leads to a long measurement time for the patient and, hereby, reduced usability, which can be a cause of irregular self-control. So far, the convergence of kinetic curves in handheld devices has been defined as the point at which the slope of the kinetic curve reaches a threshold T slope over a predefined time period [5] . This point is reached after around 3-15 s, depending on the underlying measurement. The assumption made, hereby, is that in the ideal case, measurements of equal glucose concentration will follow a similar progression at all times, and therefore, the intensity value estimate at the predefined slope threshold will be related to the underlying glucose concentration. The mapping function between intensity and glucose can be adjusted to account for the inaccuracy. While this can lead to satisfactory results when no information is given on the kinetic curve, we will show that it can also result in erroneous premature estimates. We propose to improve the performance of this approach drastically by incorporating a model of the kinetic behavior of the chemical reaction [7] , along with state estimation techniques to predict the actual convergence values ahead of time. Hereby, stages 2 and 3 of the kinetic curve depicted in Fig. 2 are modeled.
The glucose oxidase taking place on the chemical test strip can be modeled by the differential equation [7] 
where r(n) is the remission measurement value at time n, r 0 is the initial remission value after the drop, and r C is the convergence value of the relative remission after the chemical reaction has converged. We define r C to be the state that we want to predict. Furthermore, τ is the reaction rate, and v(n) is a zeromean, white, Gaussian noise process with unknown variance σ 2 v describing the measurement noise. Due to the nature of the chemical reaction, it is realistic to assume that τ and r C are correlated. Building up on [7] , we perform a regression analysis using a real dataset of estimated convergence valuesr C = [r C,1 , ...,r C,N M ] and corresponding ratesτ = [τ 1 , ...,τ N M ], N M being the number of available measurements. Hereby, we establish a linear relation between τ and r C to be the most suitable least-squares (LS) fit, as can be seen in Fig. 7τ = Δτ ·r C + τ 0 (27) where Δτ > 0 and τ 0 < 0. Using an LS fit, we estimate the regression parameters Δτ and τ 0 , to obtain from (26) the following nonlinear relation for the kinetic curve
We use an extended Kalman filter (EKF) to process the measured kinetic curve and perform an online prediction of the remission convergence value r C . For that, we formulate the prediction and measurement equations as follows:
where a(n) is the transition matrix describing the transition of the state estimater C from time n − 1 to n. In our case, a(n) = 1, as r C is a static state of the chemical reaction. The process noise is modeled by the random variable w(n) and can be used to account for uncertainty in the model. h(r C (n), v(n)) describes the observation model, relating the estimated stater C (n) to the measurementr(n). It is given by the partial derivative of the process model w.r.t. the stater
We alternate between the prediction and the correction step of the EKF, including a new measurementr(n) in each iteration.
G. Mapping to Glucose Concentration
Finally, we map the relative remission estimater C to the underlying glucose concentration, which we will deliver to the user. To this end, a calibration function f Calib :r C →ĝ is coded into the glucometer to perform the mapping during measurement. The calibration function has to be generated a priori by means of photometric measurements performed under lab conditions, using blood samples with known underlying glucose concentrations.
IV. EXPERIMENTAL RESULTS AND DISCUSSION

A. Datasets
To evaluate our proposed framework, we use real datasets, obtained from a setup as in Fig. 1 using blood samples from blood donations injected with a glucose solution corresponding to the amount of glucose needed. Altogether, we have six different datasets, comprising 452 different measurements which corresponds to a total of 263 064 processed images. The sets differ in terms of the chemical used as well as the resolution of the camera and the volume of the blood sample. This results in a different blood flow over the test strip and thereby different positions and shapes of the ROI, as well as prominence of the reaction. Information on the different datasets is given in Table I . The number of measurements in the datasets is denoted by N M , the number of different glucose concentrations tested in each dataset by N g , and the resolution of the images by Υ. The volume of the blood drop "Standard" indicates state-ofthe-art ranges around 1-25 μl [6] . Each measurement contains N f = 580 frames obtained at a frame rate of f s = 30 frames/s. All datasets are preprocessed applying a binning size of B = 5 for Υ = 6.45 μm/Pixel and B = 1 for Υ = 30 μm/Pixel. After binning, all images contain L = 1210 pixels. For the KDE, a Gaussian kernel and a fixed bandwidth parameter h as in [8] are employed. T slope is chosen to be 10 −2 . For the robust versions, as in [9] , Huber's loss function is used and its parameter tuned to achieve 95% asymptotic efficiency in the Gaussian case; IRWLS is initialized with uniform weights.
B. Validation Methods
1) Coefficient of Variation:
The coefficient of variation (CV) is a very popular measure to assess the accuracy of pharmacokinetic measurements [31] . In our work, we use the remission coefficient of variation CVr
where γ = 1, . . . , N g , andσR
andμ R g ( γ ) are the sample standard deviation and the sample mean of the elements of the setR g (γ ) , respectively.R g (γ ) denotes the test set of relative remission estimates obtained from several measurements of the same underlying glucose concentration g(γ).
2) Clarke Error Grid: The Clarke error grid (CEG) [32] is a standard method for evaluating glucose measurement performance. It plots the estimated glucose concentrations against the actual glucose concentrations and classifies the error according to its medical severity. To this end, different regions are defined in the CEG as depicted in Fig. 13 . A common specification is to have at least 95% of all points in the region A, maximally 5% of all points in the region B [33] and no points in the other zones.
3) Glucose-Specific MAD: To quantify the validation, we employ a glucose specific MAD inspired by Del Favero et al. [32] . Instead of using the standard MAD between the true and the estimated glucose level, a glucose-specific MAD (gMAD) is defined. The gMAD weighs the errors using a penalty function according to their medical severity on the basis of the CEG. Hereby, errors made for hypoglycaemic cases below 70 mg/dl are weighed with the highest factor w gMAD as they present critical short-term risks; hyperglycaemic cases which present more long-term risks are weighed with a slightly smaller factor w gMAD , and normal cases are given the factor w gMAD = 1. The gMAD reads
where the penalty function is given by
with σ(·) and σ(·) being sigmoid functions that ensure a smooth transition as given in [32] . According to the most recent ISO standards [34] , the maximal permissible error is ±15 mg/dl within a reference range of 075 mg/dl and 20% for a reference range above 75 mg/dl.
C. Results
First, we analyze the quality of the remission results. Herein, a comparison of the segmentation methods is given, as well as an analysis of the different datasets. Next, we evaluate the datadriven choice of N ν for the SS-MS. We, then, turn our attention to the effect of using the EKF to predict the convergence estimates. Finally, we study the precision of the glucose estimates after the mapping operation.
1) Kinetic Curves and Remission Accuracy: In  Fig. 8 , we present a selection of the results of the kinetic curves, i.e., the progression of the relative remission over time for the different datasets, using MS, RSS-MS, MedS, and R-MedS. For the time being, we will present the results using the standard convergence criterion, i.e., when the slope reaches a threshold of T slope for a series of consecutive frames. Overall, we establish the expected progression of the kinetic curve with its three typical stages as in Fig. 2 . We see that measurements of the same underlying glucose concentration are, mostly, bundled together. Convergence is reached faster for low-glucose concentrations than for high-glucose concentrations. Moreover, our assumption that the decay rate τ of the reaction is correlated with the underlying glucose concentration is confirmed. The higher the underlying glucose concentration, the steeper the decay. We observe a significant decrease in performance when comparing Set E with Set F, which were taken using the exact same setup and blood samples, however, using different volumes of the blood samples.
These results are underlined when analyzing the resulting CVr values for these two sets in the left part of Table II . This indicates that blood sample volumes in the range of 1 nl could be problematic. The volume range 10-100 nl, in contrast, seems to perform well. Table II shows that the medoid-shift versions are significantly better than the MS versions for all sets. Observing Set B, we notice that the difference in performance between the two methods is not as high as for other sets. The reason can be understood from Fig. 9 . The more distinct the modes are, the more separable the clusters, the better MS performs. By choosing the medoid instead of the mean and converging to actual points in the dataset, the medoid-shift does not show this bias in estimators.
The results for the SS-MS are given in the right part of Table II . We assert that the resulting CVr values are slightly worse than their nonscalable counterparts. This degradation, however, is not too severe and the loss in accuracy can be accepted to ensure lower computation. Only for Set E do we notice a severe degradation in performance, when using the SS-MS. This can be traced back to the fact that due to the very small blood volume, the ROI is much smaller than for the other measurements.
2) Data-Driven Choice of N ν for the Sparse MS: As portrayed in Section III-C3, we propose a data-driven approach to select N ν uniquely for every frame. Fig. 10 shows the choice of N ν for Set C, with N ν averaged over all frames for each measurement. The tendency matches our expectations: very low glucose concentrations are characterized by low contrast and, therefore, higher coherence. The choice of N ν is higher than for high-glucose concentrations, i.e., more data points are needed to reliably represent the image. As the concentration increases and the images become more distinct in the different regions, the variance in the choice of N ν for the same glucose concentrations decreases. Taking the worst-case scenario would have resulted in N ≈ 370 data points, which is much higher than the datadriven choice of N . Let us now analyze the quality of the SS-MS when using a data-driven choice of N ν versus a fixed N ν = 0.37 L. The results are given for the RSS-MedS in Table III . Evidently, the accuracy of both approaches is comparable. This underlines that a data-driven N ν maintains the accuracy needed.
3) State Estimation Using the EKF: The kinetic curves in Fig. 8 show that convergence for same-glucose-level measurements is not always reached at the same time, which results in strongly varying remission estimates, although the course of the kinetic curve is very similar. Let us take the 550 mg/dl measurements in Fig. 8(b) as an example. Convergence is found at times betweent C ≈ 4 s andt C ≈ 9 s, leading to remission estimates fromr C ≈ 50% tor C ≈ 59%. Fig. 11(a) shows the EKF for this example. Evidently, the EKF converges to reliable state estimates quickly, and therefore, the resultingr C estimates not only lie in the same range, but match the final convergence value of the kinetic behavior more accurately. This can be seen clearly in Fig. 11(b) . The convergence value reached by the standard methodr to the saturation values of the chemical reaction, we assert that the EKF produces more accurate results, with a gain of more than 2% in remission. Fig. 12 presents a comparison of CVr values and gMAD values for the standard convergence criterion and the EKF convergence method. This analysis considers for each set the method with the best results in Tables II and V , respectively, and compares it to its EKF-method-equivalent. The EKF convergence always leads to improved CVr values. Similarly, for the highglucose range, the gMAD results show the same outcome. For low-glucose ranges, the standard convergence compares favorably. The reason for this is that the EKF method is quite sensitive to the model used. As can be seen in Fig. 8 , the kinetic curves of low-glucose measurements exhibit a dip after the drop followed by a steady rise. This is not embodied in the model in (28) .
4) Mapping to the Underlying Glucose Concentrations: Finally, we present the results of the glucose estimateŝ g obtained by mapping the remission estimates using f Calib . The CEG plot of Set E in Fig. 13(a) shows that 93% of the points lie in region A, 6% lie in region B and 1% lie in region D using the standard convergence criterion. Thereby, the results do not conform with the requirements. As indicated by the results in Fig. 13(b) , using EKF state estimation to predict the convergence values leads to a significant improvement of the results. Now 100% of the estimates of Set E lie in the A-region. Table V presents the mean gMAD values forĝ of each set separated according to the glucose range. This analysis is omitted for Sets A and D, as they do not contain enough different glucose concentrations to construct the mapping function. The results for most sets lie below the ISO requirements, i.e., low-glucose ranges show errors smaller than gMAD = ±15 mg/dl and highglucose ranges show an error larger than 20%. However, we note that in Set E the limit is often exceeded, confirming again the fact that blood sample volumes around 1 nl are problematic.
The previously made observation concerning medoid-shift outperforming MS is confirmed again here. The robust version seems to improve the performance in high-glucose ranges more than in low-glucose ranges.
V. CONCLUSION
Regular self-control using hand-held glucometers is an indispensable part of diabetes care, and therefore, glucometers should maintain high accuracy while improving usability. We have developed a full framework to measure the blood glucose concentration from glucose images using blood sample volumes in the nl-range, which is much smaller than the state of the art, while complying with the most recent ISO standards for accuracy [34] . Using the MS principle and its variations, the R-MS and SS-MS, the intensity level of the ROI is estimated. We have shown that the scalable version of the MS with an individual selection of the number of data points gives good results w.r.t. accuracy, while decreasing the computation time. These variations are extended to the medoid-shift, which outperforms the MS in our experiments. Furthermore, the convergence of all MS and medoid-shift variations is proven. We assert that the MS and its variations are suitable for segmentation applications, where the number and size of the regions is unknown. The EKF and a model for the chemical reaction are employed to enhance the accuracy of the estimate and reduce the measurement time by around 20%. A linear relation has been found between the convergence of the glucose reaction and its decay rate. We establish that inaccuracies in the derived model can lead to degraded performance, and therefore, the model has to be calibrated uniquely for each specific setup used. As future work, we aim to enhance this model, taking into account not only the underlying glucose concentration but also incorporating affecting parameters such as temperature, humidity, and the haematocrit level [12] and viscosity of the sample. Additionally, we see the need to further validate our framework with clinical tests. Finally, we establish that very low blood sample volumes of 1 nl seem to be at the limit of what is acceptable in accuracy.
APPENDIX A PROOF OF CONVERGENCE OF THE MS ALGORITHM WITH WEIGHTS w l
Proof: Since L is finite, the sequence {f K x (j ) }, j = 1, 2, . . . is bounded. We will show that for x (j ) = x (j +1) :
. Without loss of generality, we assume x (j ) = 0, k being the profile of the kernel K(·) [19] f K x
For convex profiles and x 2 = x 1 , x 1 , x 2 ∈ [0, ∞), it follows k(x 2 ) ≥ k(x 1 ) + k (x 1 ) (x 2 − x 1 ), such that
Since k(x) is monotonically decreasing, −k (x) ≥ 0 for x ∈ [0, ∞).
is strictly positive, as are the weights w l . Hence,f K x (j +1) −f K x (j ) > 0 and the sequence {f K x (j ) } is convergent.
Without assuming x (j ) = 0 and reformulating (35), we get
Sincef K (x (j +1) ) −f K (x (j ) ) converges to zero, then ||x (j +1) − x (j ) || 2 also converges to zero and x (j ) , j = 1, 2, . . . is a Cauchy sequence.
APPENDIX B EXTENSION OF THE PROOF OF CONVERGENCE FOR THE MEDOID-SHIFT WITH WEIGHTS w l
Proof: The choice of successive points in the medoid-shift algorithm, as given in (24), is carried out according to proving thatf K x (j +1) >f K x (j ) , hence that the sequence {f K x (j ) }, j = 1, 2, . . ., is strictly positive and thus x (j ) = x (j +c) , for all c > 0. This proves that there are no cycles and medoid-shift will converge.
